CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 235.5 SEK -1.46%
Market Cap: 5.6B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CellaVision AB
Cash & Cash Equivalents Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Cash & Cash Equivalents
kr122.3m
CAGR 3-Years
10%
CAGR 5-Years
-8%
CAGR 10-Years
10%
Elekta AB (publ)
STO:EKTA B
Cash & Cash Equivalents
kr2.8B
CAGR 3-Years
-8%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Cash & Cash Equivalents
kr667.1m
CAGR 3-Years
36%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Cash & Cash Equivalents
kr2.7B
CAGR 3-Years
-23%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cash & Cash Equivalents
kr923m
CAGR 3-Years
-2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Cash & Cash Equivalents
kr90.9m
CAGR 3-Years
77%
CAGR 5-Years
23%
CAGR 10-Years
52%

See Also

What is CellaVision AB's Cash & Cash Equivalents?
Cash & Cash Equivalents
122.3m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Cash & Cash Equivalents amounts to 122.3m SEK.

What is CellaVision AB's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
10%

Over the last year, the Cash & Cash Equivalents growth was 250%. The average annual Cash & Cash Equivalents growth rates for CellaVision AB have been 10% over the past three years , -8% over the past five years , and 10% over the past ten years .

Back to Top